#1: 5 New HIV Drugs in the Pipeline
More than 36 million people worldwide are living with HIV, according to the World Health Organization (WHO). Therefore, inexpensive, effective, and long-lasting medications are essential if the scientific community wants to successfully treat them.
Problems with adherence that plagued many individuals could be alleviated with the addition of new longer-acting HIV medications. These long-acting medications may also reduce costly laboratory tests to monitor their efficacy, and bring down drug costs—a major factor in middle- and low-income countries where HIV is most prevalent.
“With several highly potent agents in the pipeline and a healthy proliferation of many promising technologies for long-acting delivery, the prospects for very long-acting ARVs [anti-retrovirals] for treatment and prevention have never been brighter,” said Matthew Barnhart MD, MPH, medical officer for the US Agency for International Development (USAID) and associate editor of Global Health: Science and Practice
in a recent editorial.
Dr. Barnhart outlined and described 5 types of drug developments that put HIV treatment on the threshold of a breakthrough.
Learn about the 5 HIV drugs in the pipeline, here
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.